This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics. This report contains market size and forecasts of Colorectal Cancer Molecular Diagnostics in global, including the following market information:
Global Colorectal Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Colorectal Cancer Molecular Diagnostics market was valued at US$ 617.9 million in 2022 and is projected to reach US$ 1504.1 million by 2029, at a CAGR of 13.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
We surveyed the Colorectal Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Global Colorectal Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-Party Testing Agency
Others
Global Colorectal Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Colorectal Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Colorectal Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Colorectal Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Colorectal Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colorectal Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Colorectal Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colorectal Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colorectal Cancer Molecular Diagnostics Overall Market Size
2.1 Global Colorectal Cancer Molecular Diagnostics Market Size: 2022 VS 2029
2.2 Global Colorectal Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Colorectal Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Colorectal Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Colorectal Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Colorectal Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Colorectal Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Colorectal Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Colorectal Cancer Molecular Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction PCR
4.1.3 Molecular Hybridization
4.1.4 Biochip
4.1.5 Others
4.2 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colorectal Cancer Molecular Diagnostics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-Party Testing Agency
5.1.4 Others
5.2 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Colorectal Cancer Molecular Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Colorectal Cancer Molecular Diagnostics Revenue, 2018-2029
6.3.2 US Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.3.3 Canada Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.3.4 Mexico Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue, 2018-2029
6.4.2 Germany Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.3 France Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.4 U.K. Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.5 Italy Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.6 Russia Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.8 Benelux Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue, 2018-2029
6.5.2 China Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.3 Japan Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.4 South Korea Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.6 India Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Colorectal Cancer Molecular Diagnostics Revenue, 2018-2029
6.6.2 Brazil Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.6.3 Argentina Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue, 2018-2029
6.7.2 Turkey Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.7.3 Israel Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
6.7.5 UAE Colorectal Cancer Molecular Diagnostics Market Size, 2018-2029
7 Colorectal Cancer Molecular Diagnostics Companies Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Abbott Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Thermo Fisher
7.3.1 Thermo Fisher Company Summary
7.3.2 Thermo Fisher Business Overview
7.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Key News & Latest Developments
7.4 Qiagen
7.4.1 Qiagen Company Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.4.4 Qiagen Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Qiagen Key News & Latest Developments
7.5 Illumina
7.5.1 Illumina Company Summary
7.5.2 Illumina Business Overview
7.5.3 Illumina Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Illumina Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Illumina Key News & Latest Developments
7.6 Biomerieux
7.6.1 Biomerieux Company Summary
7.6.2 Biomerieux Business Overview
7.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.6.4 Biomerieux Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Biomerieux Key News & Latest Developments
7.7 Bio-Rad
7.7.1 Bio-Rad Company Summary
7.7.2 Bio-Rad Business Overview
7.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Bio-Rad Key News & Latest Developments
7.8 Agilent
7.8.1 Agilent Company Summary
7.8.2 Agilent Business Overview
7.8.3 Agilent Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Agilent Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Agilent Key News & Latest Developments
7.9 Daangene
7.9.1 Daangene Company Summary
7.9.2 Daangene Business Overview
7.9.3 Daangene Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Daangene Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Daangene Key News & Latest Developments
7.10 Amoydx
7.10.1 Amoydx Company Summary
7.10.2 Amoydx Business Overview
7.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Amoydx Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Amoydx Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Colorectal Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Colorectal Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Colorectal Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Colorectal Cancer Molecular Diagnostics in Global Market
Table 5. Top Colorectal Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Colorectal Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Colorectal Cancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Colorectal Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Colorectal Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colorectal Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Roche Diagnostics Company Summary
Table 31. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product Offerings
Table 32. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Diagnostics Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Colorectal Cancer Molecular Diagnostics Product Offerings
Table 36. Abbott Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. Thermo Fisher Company Summary
Table 39. Thermo Fisher Colorectal Cancer Molecular Diagnostics Product Offerings
Table 40. Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Thermo Fisher Key News & Latest Developments
Table 42. Qiagen Company Summary
Table 43. Qiagen Colorectal Cancer Molecular Diagnostics Product Offerings
Table 44. Qiagen Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Qiagen Key News & Latest Developments
Table 46. Illumina Company Summary
Table 47. Illumina Colorectal Cancer Molecular Diagnostics Product Offerings
Table 48. Illumina Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Illumina Key News & Latest Developments
Table 50. Biomerieux Company Summary
Table 51. Biomerieux Colorectal Cancer Molecular Diagnostics Product Offerings
Table 52. Biomerieux Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Biomerieux Key News & Latest Developments
Table 54. Bio-Rad Company Summary
Table 55. Bio-Rad Colorectal Cancer Molecular Diagnostics Product Offerings
Table 56. Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Bio-Rad Key News & Latest Developments
Table 58. Agilent Company Summary
Table 59. Agilent Colorectal Cancer Molecular Diagnostics Product Offerings
Table 60. Agilent Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Agilent Key News & Latest Developments
Table 62. Daangene Company Summary
Table 63. Daangene Colorectal Cancer Molecular Diagnostics Product Offerings
Table 64. Daangene Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Daangene Key News & Latest Developments
Table 66. Amoydx Company Summary
Table 67. Amoydx Colorectal Cancer Molecular Diagnostics Product Offerings
Table 68. Amoydx Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Amoydx Key News & Latest Developments
List of Figures
Figure 1. Colorectal Cancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Colorectal Cancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Colorectal Cancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Colorectal Cancer Molecular Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Colorectal Cancer Molecular Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Qiagen Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Illumina Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biomerieux Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Agilent Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Daangene Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Amoydx Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
